Skip to main content
letter
. 2023 Sep 6;27:348. doi: 10.1186/s13054-023-04619-y

Table 1.

Mortality type and CRP reported in the included study

References Year Reported mortality How CRP was integrated
Dequin et al. [6] 2023 28-day and 90-day mortality Reported in baseline, in subgroup analysis (threshold: 15 mg/dL)
Meduri et al. [7] 2022 All-cause mortality at days 60, 180 and 365 Not indicated
Torres et al. [5] 2015 Death within 72 and 120 h of treatment, in-hospital mortality Reported in baseline; clinical outcomes were compared between patients with a still high CRP (> 130 mg/L) at day 7 and those who were not
Sabry et al. [8] 2011 Mortality by day 8 Reported in baseline and was compared on day 2, 4, 6 and 8
El-Ghamrawy et al. [9] 2006 Reported mortality rate without specifying the type Not indicated
Confalonier et al. [10] 2005 Mortality by day 8, ICU mortality, hospital mortality and 60-day mortality Reported in baseline and was compared on day 1, 2, 3, 6 and 8
Marik et al. [11] 1993 Reported mortality rate without specifying the type Not indicated

CRP C-reactive protein, ICU intensive care unit